BTAI icon

BioXcel Therapeutics
BTAI

Overview Fund Activity

108 hedge funds and large institutions have $512M invested in BioXcel Therapeutics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 21 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+4
Holders Change %
+3.85%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
25
Increased
50
Reduced
21
Closed
21
Calls
$23.3M
Puts
$7.13M
Net Calls
+$16.2M
Net Calls Change
+$1.59M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$83.5M
2
Victory Capital Management
Victory Capital Management
Texas
$25.8M
3
Citadel Advisors
Citadel Advisors
Florida
$32.5M
4
State Street
State Street
Massachusetts
$56.1M
5
AIM
Artemis Investment Management
United Kingdom
$43.4M

Top Sellers

1
ACP
Acuta Capital Partners
California
$0
2
DCM
Driehaus Capital Management
Illinois
$520K
3
IC
Ikarian Capital
Texas
$117K
4
Renaissance Technologies
Renaissance Technologies
New York
$0
5
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FANJ
126
Financial Architects (New Jersey)
New Jersey
– -$53K -63 Closed
PAG
127
Private Advisor Group
New Jersey
– -$6K -7 Closed
PWP
128
Principle Wealth Partners
Connecticut
– -$1K -1 Closed
2 3 4 5
6